FLEXCARE
FLEXCARE, licence 80058365: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Titan Distribution
- NPN or DIN-HM
- 80058365
- Status
- Inactive licence
- Licence date
- 20 February 2015
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Salix alba L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Salix alba Source : Écorce | 25.0 mg | Not calculated |
| Vitamine C Source : Acide ascorbique | 50.0 mg | 150,000 µg |
| Harpagophytum procumbens Source : Dried secondary root tuber | 25.0 mg | Not calculated |
| Sulfate de chondroïtine Source : Sulfate de chondroïtine sodique provenant d¿un ou de plusieurs de cartilage de bovins | 150.0 mg | Not calculated |
| Sulfate de 2-amino-2-désoxy-D-glucose Source : Sulfate de glucosamine chlorure de pottasium provenant d¿exosquelettes de crevettes | 300.0 mg | Not calculated |
| Sulfate de 2-amino-2-désoxy-D-glucose Source : Sulfate de glucosamine chlorure de pottasium provenant d¿exosquelettes de crabes | 300.0 mg | Not calculated |
| L-Glutamine Source : L-Glutamine | 50.0 mg | Not calculated |
| Méthylsulfonylméthane | 250.0 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Microcrystalline cellulose, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | 3.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps relieve joint pain associated with osteoarthritis (of the knee). Helps in the development and maintenance of bones, cartilage, teeth, and gums. Helps in connective tissue formation. Helps in wound healing. An antioxidant for the maintenance of good health. A workout supplement. Athletic support. Source of an amino acid involved in muscle protein synthesis. Helps the body to metabolize fats and proteins
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80058365
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.